Understanding Senescence Signaling in Tumors
Author Information
Author(s): Lafferty-Whyte Kyle, Bilsland Alan, Cairney Claire J, Hanley Lorna, Jamieson Nigel B, Zaffaroni Nadia, Oien Karin A, Burns Sharon, Roffey Jon, Boyd Susan M, Keith W Nicol
Primary Institution: Centre for Oncology and Applied Pharmacology, University of Glasgow
Hypothesis
Can senescence scoring reveal the relationship between senescence signaling and drug toxicity in human tumors?
Conclusion
The study demonstrates that senescence scoring effectively captures senescence signaling in various tumor contexts and correlates with drug toxicity.
Supporting Evidence
- Senescence scoring captures differential induction of damage or inflammatory pathways.
- A pro-inflammatory signature showed prognostic significance in mesothelioma.
- Senescence scores correlated with growth inhibition in response to ~1500 compounds in the NCI60 panel.
Takeaway
This study looks at how certain signals in cancer cells can show if they are aging or responding to treatment, which can help doctors choose better therapies.
Methodology
The study used a scoring approach based on gene expression profiles of senescence markers to analyze public datasets and their own tumor samples.
Potential Biases
Potential biases may arise from the selection of datasets and the interpretation of gene expression data.
Limitations
The study primarily relies on existing datasets, which may limit the generalizability of the findings.
Participant Demographics
The study analyzed data from various human tumor types, including colon adenocarcinoma, breast cancer, melanoma, and mesenchymal tumors.
Statistical Information
P-Value
0.0015
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website